Hypopigmentation in the sites of regressed melanoma metastases after successful dacarbazine therapy

Int J Dermatol. 2012 Sep;51(9):1142-4. doi: 10.1111/j.1365-4632.2010.04731.x. Epub 2011 Sep 14.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / adverse effects*
  • Dacarbazine / adverse effects*
  • Forearm
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / secondary*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Hyperpigmentation / chemically induced*
  • Hyperpigmentation / pathology
  • Male
  • Melanoma / drug therapy
  • Melanoma / secondary*
  • Melanoma / surgery
  • Middle Aged
  • Scalp*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / surgery
  • Torso

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine